Inventor
SAFINA BRIAN
US38 patents
⚠️ This page may combine multiple inventors who share the name “SAFINA BRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
21 patentsUS8933236B2Jan 13, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC50 citations97
US8952169B2Feb 10, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC25 citations92
US9771376B2Sep 26, 2017
N-substituted benzamides and methods of use thereof
GENENTECH INC7 citations84
US10005724B2Jun 26, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC6 citations83
US9694002B2Jul 4, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC11 citations83
US9546164B2Jan 17, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC13 citations83
US8563540B2Oct 22, 2013
Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
GENENTECH INC6 citations83
US10533058B2Jan 14, 2020
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC2 citations72
US10125098B2Nov 13, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC2 citations72
US9550775B2Jan 24, 2017
Substituted triazolopyridines and methods of use thereof
GENENTECH INC7 citations72
US10124069B2Nov 13, 2018
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC3 citations71
US11692043B2Jul 4, 2023
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC0 citations61
US10787446B2Sep 29, 2020
Therapeutic compounds and methods of use thereof
GENENTECH INC1 citations59
US10071957B2Sep 11, 2018
N-substituted benzamides and methods of use thereof
GENENTECH INC1 citations52
US10632210B2Apr 28, 2020
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC0 citations51
US10179767B2Jan 15, 2019
Substituted benzamides and methods of use thereof
GENENTECH INC0 citations51
US9999681B2Jun 19, 2018
Peptidomimetic compounds and antibody-drug conjugates thereof
GENENTECH INC1 citations51
US10711004B2Jul 14, 2020
Oxadiazole transient receptor potential channel inhibitors
GENENTECH INC0 citations37
US10544215B2Jan 28, 2020
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
GENENTECH INC0 citations37
US10442836B2Oct 15, 2019
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
GENENTECH INC0 citations37
US7749994B2Jul 6, 2010
Pentacyclic kinase inhibitors
GENENTECH INC0 citations37
CASTANEDO GEORGETTE
4 patentsUS8394796B2Mar 12, 2013
Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE8 citations82
US8173650B2May 8, 2012
Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE7 citations82
US8158625B2Apr 17, 2012
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE6 citations71
US8440651B2May 14, 2013
Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
CASTANEDO GEORGETTE4 citations61
MITCHELL IAN S
3 patentsUS8063050B2Nov 22, 2011
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S63 citations97
US8853199B2Oct 7, 2014
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S20 citations92
US8846681B2Sep 30, 2014
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S11 citations83
BOLT BIOTHERAPEUTICS INC
3 patentsUS11654199B2May 23, 2023
Thienoazepine immunoconjugates, and uses thereof
BOLT BIOTHERAPEUTICS INC2 citations67
US12465653B2Nov 11, 2025
Thienoazepine immunoconjugates, and uses thereof
BOLT BIOTHERAPEUTICS INC0 citations57
US12570610B2Mar 10, 2026
Macromolecule-supported aminobenzazepine compounds
BOLT BIOTHERAPEUTICS INC0 citations42